Next 10 |
2024-03-27 09:15:03 ET Canaccord Genuity analyst issues BUY recommendation for DCTH on March 27, 2024 08:09AM ET. The previous analyst recommendation was Buy. DCTH was trading at $4.61 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curre...
2024-03-26 12:49:07 ET Delcath Systems Inc (DCTH) Q4 2023 Results Conference Call March 26, 2024 8:30 AM ET Company Participants David Hoffman - General Counsel, Corporate Secretary & Chief Compliance Officer Gerard Michel - CEO & Director Sandra Pennell ...
2024-03-26 07:33:09 ET More on Delcath Systems Delcath Systems announces $7 million private placement Delcath Systems announces CMS established product-specific J-code for HEPZATO Seeking Alpha’s Quant Rating on Delcath Systems Historical earnings data...
Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update PR Newswire Increases 2024 Treatment Site Activation Guidance to 20 Sites QUEENSBURY, N.Y. , March 26, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH)...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...
2024-03-25 13:22:47 ET More on Delcath Systems Delcath Systems announces $7 million private placement Delcath Systems announces CMS established product-specific J-code for HEPZATO Seeking Alpha’s Quant Rating on Delcath Systems Historical earnings data...
2024-03-24 08:01:00 ET Westport Fuel Systems ( WPRT ) is set to report its Q4 earnings on Monday after the closing bell. The stock, which has dropped about 24% over a 12-month period, has received a Buy rating from Wall Street analysts, while Seeking Alpha's Quant Rating system has ...
Delcath Systems Closes $7 Million Private Placement PR Newswire NEW YORK , March 20, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, confirmed the closi...
Delcath Systems to Host Fourth Quarter and Full Year 2023 Results and Business Update Call PR Newswire NEW YORK , March 19, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and m...
2024-03-18 17:25:15 ET More on Delcath Systems Delcath Systems announces $7 million private placement Delcath Systems announces CMS established product-specific J-code for HEPZATO Seeking Alpha’s Quant Rating on Delcath Systems Read the full article ...
News, Short Squeeze, Breakout and More Instantly...
Delcath Systems Inc. Company Name:
DCTH Stock Symbol:
OTCMKTS Market:
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
2024-03-27 09:15:03 ET Canaccord Genuity analyst issues BUY recommendation for DCTH on March 27, 2024 08:09AM ET. The previous analyst recommendation was Buy. DCTH was trading at $4.61 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curre...
Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update PR Newswire Increases 2024 Treatment Site Activation Guidance to 20 Sites QUEENSBURY, N.Y. , March 26, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH)...